Amundi
- SEC CIK
- 0001330387
- Latest filing
- Aug 26, 2026
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 15,894
- Value
- $403.2K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 15,894 | $403.2K | <0.1% | +2,210+16.2% | Added | Holders |
| Q1 2026 | 13,684 | $309.3K | <0.1% | +13,684 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −18,723−100.0% | Sold out | Holders |
| Q1 2025 | 18,723 | $454.8K | <0.1% | −4,391−19.0% | Reduced | Holders |
| Q4 2024 | 23,114 | $429.5K | <0.1% | +15,431+200.8% | Added | Holders |
| Q3 2024 | 7,683 | $120.3K | <0.1% | +711+10.2% | Added | Holders |
| Q2 2024 | 6,972 | $151.0K | <0.1% | +6,972 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −2,635−100.0% | Sold out | Holders |
| Q3 2022 | 2,635 | $149.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,635 | $139.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,635 | $214.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,635 | $162.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,635 | $148.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 2,635 | $160.0K | <0.1% | – | No prior filing | Holders |